Part 2. The post comes as a part of the series on the growing requirements of HCQ world wide. Global clinical trials are on for this very age old drug to collect additional and supporting evidence for treatment for COVID -19 virus. Simultaneously , there is a dire need to ramp up production of the …

Continue reading “The dilemma of HCQ production continues… Part 2”

This post comes as a part of the series of developments which are influencing the HCQ clinical trial market. Aggressive efforts of the developed and developing countries which are focused on new drug and vaccine research focused Clinical trials for Corona virus. Nearly 1000 multi centric trials for corona virus are currently in progress as …

Continue reading “Emerging clinical trials in COVID-19”

Will Indian pharma be able to overcome the challenges it faces in the COVID -19 crisis? Indian pharma which has less than 20 players in the HCQ formulation ( tablet ) market which is working day and night to enhance supplies of HCQ tablets for its Corona virus patients in India. Interestingly, HCQ is no …

Continue reading “The dilemma of HCQ production”